title: The effect of adrenomedullin, amylin fragment 8-37 and calcitonin gene-related peptide on contractile force, heart rate and coronary perfusion pressure in isolated rat hearts.
abstract: The effect of human adrenomedullin, human amylin fragment 8-37 (amylin 8-37) and rat calcitonin gene-related peptide (CGRP) on contractile force, heart rate and coronary perfusion pressure has been investigated in the isolated perfused rat hearts. Adrenomedullin (2x10(-10), 2x10(-9) and 2x10(-8) M) produced a significant decrease in contractile force and perfusion pressure, but only the peptide caused a decline in heart rate at the highest dose. Amylin (10(-9), 10(-8) and 10(-7) M) significantly increased and then decreased contractile force. Two doses of amylin (10(-8) and 10(-7) M) induced a significant increase in heart rate, however amylin did not change perfusion pressure in all the doses used. Rat alpha CGRP (10(-8), 10(-7) and 10(-6) M) evoked a slight decline in contractile force following a significant increase in contractile force induced by the peptide. CGRP in all the doses raised heart rate and lowered perfusion pressure. Our results suggest that adrenomedullin has negative inotropic, negative chronotropic and coronary vasodilator actions. Amylin produces a biphasic inotropic effect and evokes a positive chronotropy. CGRP causes positive inotropic, positive chronotropic and vasodilatory effects in isolated rat hearts.
authors.affiliation: Department of Physiology, Medical Faculty, Osmangazi University, Eskişehir, Turkey.
authors.forename: Z
authors.initials: Z
authors.lastname: Kaygisiz
authors.forename: N
authors.initials: N
authors.lastname: Erksap
authors.forename: R
authors.initials: R
authors.lastname: Uyar
authors.forename: S
authors.initials: S
authors.lastname: Kabadere
authors.forename: T E
authors.initials: TE
authors.lastname: Kabadere
authors.forename: S
authors.initials: S
authors.lastname: Dernek
mesh_terms: D053607:Adrenomedullin; D000682:Amyloid / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism / Q000494:pharmacology*; D002316:Cardiotonic Agents / Q000494:pharmacology*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects* / Q000502:physiology; D009924:Organ Culture Techniques; D010446:Peptide Fragments / Q000378:metabolism / Q000494:pharmacology*; D010455:Peptides / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D011673:Pulsatile Flow / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013268:Stimulation, Chemical
chemical_list: D000682:Amyloid; D002316:Cardiotonic Agents; D010446:Peptide Fragments; D010455:Peptides; C109255:amylin (8-37); D053607:Adrenomedullin; D015740:Calcitonin Gene-Related Peptide